Abstract:Background Spondyloarthropathy is a group of systemic chronic autoimmune diseases, which is characterised by the spine, peripheral joint, joint tissue inflammation and high morbidity. And ocular inflammatory disorders are the most common and important extra-articular manifestations with unclear pathogenesis. The imbalance of T help 17 cells (Th17)/regulatory T cells is considered to be a pivotal cause of autoimmune diseases, their roles in spondyloarthropathy, especially the related oculopathy, are rare studied. Objectives To explore the status of both absolute number and percentage of CD4 +CD25+Foxp3+T regulatory (CD4Treg) cells and Th17 cells in peripheral blood (PB) of patients with spondyloarthropathy-related oculopathy. Methods Ninety six patients were enrolled, including fifty spondyloarthropathy without related oculopathy (Group A), mean age of 43.23±11.49 years, and fourty six spondyloarthropathy-related oculopathy (Group B), mean age of 43.50±13.51 years. BD Trucount tubes with the lyophilized pellet of a known number of internal counting beads were used for determining absolute counts of total CD4 +T cells in PB and then calculating the absolute number of Th17 cells and CD4Treg. Ninety three healthy volunteers, matched for patients’ age and gender, were also included for the estimation of CD4 +T cell subsets. Results As compared to healthy controls (median of CD4Treg cells: 33.06 cells/ul), the frequencies of circulating CD4Treg cells were significantly decreased in both spondyloarthropathy without related oculopathy (median: 25.07 cells/ul, p<0.05) and spondyloarthropathy-related oculopathy (median: 17.65 cells/ul, p<0.001). The median ratios of Th17/CD4Treg cells in each group of patients were greatly higher than those of healthy volunteers [Group A: 0.29 (0.22, 0.47) vs. 0.21 (0.15, 0.34), p<0.01; Group B: 0.32 (0.21, 0.55) vs. 0.21 (0.15, 0.34), p<0.01]. Nevertheless, there were not significantly different in circulating Th17 cell changes among the three groups. Moreover, there was more absolute reduction of peripheral CD4Treg cells in Group B than Group A (p=0.006), while greater increase in the ratio of Th17/CD4Treg despite no statistical significance (p>0.05). Conclusions The reduction of CD4Treg but not the elevation of Th17 cells may be the major reason for imbalance of Th17/CD4Treg. It is speculated that spondyloarthropathy-related oculopathy is an autoimmune disease triggered by the defect of immunotolerance. More importantly, the recovery of CD4Treg may be a potential target treatment for patients with spondyloarthropathy-related oculopathy. References [1] Alunno A, Manetti M, Caterbi S, et al. Altered immunoregulation in rheumatoid arthritis: The role of regulatory t cells and proinflammatory th17 cells and therapeutic implications [J]. Mediators Inflamm2015;2015:751793. [2] Zagora SL, Mccluskey P. Ocular manifestations of seronegative spondyloarthropathies [J]. Curr Opin Ophthalmol2014;25(6):495–501. [3] Khan MA, Haroon M, Rosenbaum JT. Acute anterior uveitis and spondyloarthritis: more than meets the eye [J]. Curr Rheumatol Rep2015;17(9): 59. Acknowledgements We would like to express our sincere gratitude to all our coworkers and collaborators, to Jing Luo, Xiangcong Zhao, Chen Zhang, Qi Wu, Congcong Liang, and Rui Fu for their technical support. Disclosure of Interest None declared

Deficiency of Peripheral CLA+ Tregs and Clinical Relevance in Behcet’s Syndrome

Deficiency of peripheral CLA+ Tregs and clinical relevance in Behcet's syndrome

Ischaemic Heart Disease in Behçet's Syndrome: a Systematic Review and Meta-Analysis

FRI0450 Associations of alterations of peripheral regulatory t and th17 absolute cell numbers with clinical features in patients with systemic sclerosis

Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study

Comprehensive analysis of T-cell receptor repertoires reveals antigen-driven T-cell clusters in patients with Behçet's syndrome

Phenotypes and clinical significance of circulating CD4 + CD25 + regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)

Risk Factors of Disease Activity in Patients with Behçet’s Syndrome

[The distribution of biomarkers for Behcet syndrome and their clinical relevance in real-world studies]

Profile of Immunological Biomarkers in Behcet’s Syndrome: a Large-Scale Single-Center Real-World Study

Characteristics of T Cell Receptor Beta Repertoires Associated With Behçet’s Syndrome Patients With Major Organ Involvements

Clinical Characteristics and Risk Factors of Intestinal Involvement in Behçet’s Syndrome Patients: a Cross-Sectional Study from a Single Center

DIFFERENTIAL EXPRESSION OF PERIPHERAL CD4+T CELLS IN PATIENTS WITH SYSTEMIC SCLEROSIS AND MIXED CONNECTIVE TISSUE DISEASE

THU0412 Absolute reduction of peripheral cd4 + regulatory t cell subset of patients with systemic sclerosis and its restoration by short-term and low dose il-2 treatment

THU0229 Absolute Reduction of Peripheral Cd4+cd25+foxp3+t Regulatory Cells in Patients with Spondyloarthropathy-Related Oculopathy

Regulatory T cells and Behcet disease

New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation

Clinical phenotypes of adult-onset Behçet's syndrome: a comprehensive cross-sectional study in China

Cluster Analysis of Phenotypes of Patients with Behçet's Syndrome: a Large Cohort Study from a Referral Center in China.

TMT and PRM-Based Quantitative Proteomics Identify Potential Biomarkers for Behçet Syndrome

Efficacy and Safety of Low-Dose Interleukin 2 for Behçet’s Syndrome: a Phase 2 Randomized Double-Blind Placebo-Controlled Clinical Trial